Shareholders are very likely to turn down the Michael Saylor pitch, Polymarket bettors are predicting. …
Vaxcyte Announces Pricing of Concurrent Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes
SAN CARLOS, Calif., Oct. 06, 2026 (GLOBE NEWSWIRE) — Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage …